---
title: Pentoxifylline
description: >-
  Pentoxifylline is prescribed for the symptomatic treatment of intermittent
  claudication, a condition characterized by pain and cramping in the legs
  during exercise due to reduced blood flow.  It is also used in other
  conditions where improved blood flow is beneficial, such as cerebrovascular
  dise...
is_banned: false
lastModified: '2025-09-22T17:21:53.876Z'
faqs:
  - q: >-
      What is the recommended dosage for Pentoxifylline?**

      **A:** The standard adult dose is 400 mg two to three times a day with
      meals, not exceeding 1200 mg daily. Dose adjustments are needed for renal
      or hepatic impairment and elderly patients.
    a: >-
      A:** The standard adult dose is 400 mg two to three times a day with
      meals, not exceeding 1200 mg daily. Dose adjustments are needed for renal
      or hepatic impairment and elderly patients.
  - q: >-
      What is the mechanism of action of Pentoxifylline?**

      **A:**  Pentoxifylline decreases blood viscosity primarily by increasing
      red blood cell deformability and inhibiting platelet aggregation.  This
      improves blood flow, particularly in the microcirculation.
    a: >-
      A:**  Pentoxifylline decreases blood viscosity primarily by increasing red
      blood cell deformability and inhibiting platelet aggregation.  This
      improves blood flow, particularly in the microcirculation.
  - q: >-
      What are the most common side effects of Pentoxifylline?**

      **A:** The most common side effects include nausea, vomiting, dyspepsia,
      dizziness, headache, and flushing.
    a: >-
      A:** The most common side effects include nausea, vomiting, dyspepsia,
      dizziness, headache, and flushing.
  - q: >-
      Is Pentoxifylline safe to use during pregnancy?**

      **A:** Pentoxifylline is Pregnancy Category C and should generally be
      avoided during pregnancy unless the benefit clearly outweighs the
      potential risk to the fetus.
    a: >-
      A:** Pentoxifylline is Pregnancy Category C and should generally be
      avoided during pregnancy unless the benefit clearly outweighs the
      potential risk to the fetus.
  - q: >-
      What are the contraindications for using Pentoxifylline?**

      **A:**  Pentoxifylline is contraindicated in patients with
      hypersensitivity to the drug or other methylxanthines, recent cerebral or
      retinal hemorrhage, and acute myocardial infarction.
    a: >-
      A:**  Pentoxifylline is contraindicated in patients with hypersensitivity
      to the drug or other methylxanthines, recent cerebral or retinal
      hemorrhage, and acute myocardial infarction.
  - q: >-
      How should Pentoxifylline be administered?**

      **A:**  Pentoxifylline should be administered orally, preferably with
      meals, to reduce gastrointestinal side effects.  Extended-release
      formulations should be swallowed whole and not crushed or chewed.
    a: >-
      A:**  Pentoxifylline should be administered orally, preferably with meals,
      to reduce gastrointestinal side effects.  Extended-release formulations
      should be swallowed whole and not crushed or chewed.
  - q: >-
      Does Pentoxifylline interact with other medications?**

      **A:** Yes, it can interact with antihypertensives, anticoagulants,
      cimetidine, and theophylline.  It can also interact with drugs metabolized
      by CYP1A2 and CYP2D6.
    a: >-
      A:** Yes, it can interact with antihypertensives, anticoagulants,
      cimetidine, and theophylline.  It can also interact with drugs metabolized
      by CYP1A2 and CYP2D6.
  - q: >-
      How long does it take for Pentoxifylline to work?**

      **A:** It may take up to two months to see the full therapeutic effect of
      Pentoxifylline.
    a: >-
      A:** It may take up to two months to see the full therapeutic effect of
      Pentoxifylline.
  - q: >-
      Can Pentoxifylline be used in children?**

      **A:** The safety and efficacy of pentoxifylline have not been established
      in children, and it is generally not recommended for pediatric use.
    a: >-
      A:** The safety and efficacy of pentoxifylline have not been established
      in children, and it is generally not recommended for pediatric use.
  - q: >-
      What monitoring is recommended for patients taking Pentoxifylline?**

      **A:** Monitor blood pressure, complete blood count (CBC), and liver
      function tests regularly, especially in patients with pre-existing
      conditions.  Monitor for signs of bleeding.
    a: >-
      A:** Monitor blood pressure, complete blood count (CBC), and liver
      function tests regularly, especially in patients with pre-existing
      conditions.  Monitor for signs of bleeding.
---
## **Usage**

Pentoxifylline is prescribed for the symptomatic treatment of intermittent claudication, a condition characterized by pain and cramping in the legs during exercise due to reduced blood flow.  It is also used in other conditions where improved blood flow is beneficial, such as cerebrovascular disease and venous leg ulcers.  Its pharmacological classification is a hemorrheologic agent, specifically a methylxanthine derivative. It improves blood flow by decreasing blood viscosity and increasing red blood cell deformability, enabling better passage through narrowed blood vessels and consequently enhancing tissue oxygenation.

## **Alternate Names**

- International Nonproprietary Name (INN): Pentoxifylline
- Other Names: Oxpentifylline
- Brand Names: Trental, Pentoxil, and various generics

## **How It Works**

**Pharmacodynamics:** Pentoxifylline's primary mechanism of action involves reducing blood viscosity and increasing red blood cell flexibility. It affects red blood cells by inhibiting phosphodiesterase, leading to increased intracellular cyclic AMP (cAMP) levels. This increase in cAMP subsequently decreases intracellular calcium concentration, promoting red blood cell deformability and reducing platelet aggregation. These effects improve microcirculation and enhance tissue oxygenation.

**Pharmacokinetics:** Pentoxifylline is almost completely absorbed after oral administration but undergoes extensive first-pass metabolism in the liver. The three major active metabolites (M1, M4, and M5) contribute significantly to the drug's therapeutic effect. Peak plasma concentrations of the parent drug and its metabolites are typically reached within 1 hour after oral administration of a solution, but later with extended-release formulations. It is primarily metabolized in the liver by CYP enzymes, specifically CYP1A2 and CYP2D6.  Elimination is primarily through renal excretion.

## **Dosage**

### **Standard Dosage**

#### **Adults:**

- The standard dose is 400 mg two to three times daily, taken with meals.
- The maximum recommended dose is 1200 mg daily (400 mg three times a day). 
- It may take up to two months to achieve full therapeutic benefit.

#### **Children:**

- The safety and efficacy of pentoxifylline in children have not been established, and it is not recommended for pediatric use.

#### **Special Cases:**

- **Elderly Patients:** Initiate therapy with a lower dose due to increased risk of adverse effects related to higher plasma levels of metabolites.
- **Patients with Renal Impairment:** For patients with creatinine clearance below 30 mL/min, reduce the dose to 400 mg/day.
- **Patients with Hepatic Dysfunction:** Use with caution in mild to moderate liver impairment and avoid in severe hepatic impairment. Careful dose adjustment is needed, as pentoxifylline is metabolized in the liver.
- **Patients with Comorbid Conditions:** Dose adjustments may be necessary depending on concomitant diseases and other medications. Especially for patients with diabetes or cardiovascular disease, careful monitoring is warranted.

### **Clinical Use Cases**

Pentoxifylline's primary indication is intermittent claudication; there are no specific dosing guidelines for other medical procedures, including intubation, surgical procedures, mechanical ventilation, ICU use, or emergency situations.

### **Dosage Adjustments**

Dosage adjustments are necessary based on individual patient factors, including renal impairment, hepatic dysfunction, and potential drug interactions.  For patients experiencing gastrointestinal or central nervous system side effects, the dose can be reduced to 400 mg twice daily.


## **Side Effects**

### **Common Side Effects:**
- Nausea, vomiting, dyspepsia (indigestion), abdominal discomfort, bloating, diarrhea, dizziness, headache, blurred vision, flushing.

### **Rare but Serious Side Effects:**
- Chest pain, arrhythmias, angina, hypotension, shortness of breath, cholecystitis, hepatitis, seizures, anaphylaxis, bleeding (especially in patients with ulcers or recent surgery), blood dyscrasias (leukopenia, thrombocytopenia, pancytopenia).

### **Long-Term Effects:**
- Long-term use may potentially exacerbate underlying cardiovascular conditions or renal insufficiency.


### **Adverse Drug Reactions (ADR)**
- Angina, severe allergic reactions (including anaphylaxis), cholestatic jaundice, and severe bleeding.


## **Contraindications**

- Hypersensitivity to pentoxifylline or other methylxanthines (caffeine, theophylline, theobromine).
- Recent cerebral or retinal hemorrhage.
- Acute myocardial infarction.
- Severe coronary artery disease.

## **Drug Interactions**

- **Antihypertensives:** Pentoxifylline may potentiate the effects of antihypertensive medications.
- **Anticoagulants/Antiplatelets:** Concomitant use with warfarin or other anticoagulants/antiplatelets may increase the risk of bleeding.
- **Cimetidine:** May increase pentoxifylline plasma concentrations.
- **Theophylline:** Increased risk of theophylline toxicity.
- **CYP450 interactions:** May interact with drugs metabolized by CYP1A2 and CYP2D6.

## **Pregnancy and Breastfeeding**

- **Pregnancy:** Pentoxifylline is classified as Pregnancy Category C.  It should be avoided during pregnancy unless the potential benefit outweighs the potential risk to the fetus.  
- **Breastfeeding:** Pentoxifylline and its metabolites are excreted in human milk.  The decision to discontinue breastfeeding or the drug should be made considering the importance of the drug to the mother.

## **Drug Profile Summary**

- **Mechanism of Action:** Decreases blood viscosity and improves red blood cell deformability.
- **Side Effects:** Nausea, vomiting, dyspepsia, dizziness, headache, flushing, chest pain, bleeding.
- **Contraindications:** Hypersensitivity, recent hemorrhage, MI, severe CAD.
- **Drug Interactions:** Antihypertensives, anticoagulants, cimetidine, theophylline.
- **Pregnancy & Breastfeeding:** Category C; excreted in breast milk.
- **Dosage:** 400 mg two to three times daily with meals.
- **Monitoring Parameters:** Blood pressure, complete blood count (CBC), liver function tests.

## **Popular Combinations**

While pentoxifylline may be used in conjunction with other medications to address underlying conditions or risk factors (e.g., antihypertensives, antiplatelet agents), there are no specific drug combinations commonly considered as standard practice.  The use of any combined therapy should be individualized according to patient-specific needs.

## **Precautions**

- **General Precautions:** Monitor for bleeding, especially in patients with risk factors. Monitor liver and kidney function.
- **Specific Populations:** Use with caution in the elderly and patients with renal or hepatic impairment. Avoid use during pregnancy unless the benefit clearly outweighs the risk. Caution during breastfeeding. Pediatric use not recommended.
- **Lifestyle Considerations:** Avoid alcohol, as it can increase the risk of side effects.



## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Pentoxifylline?**
**A:** The standard adult dose is 400 mg two to three times a day with meals, not exceeding 1200 mg daily. Dose adjustments are needed for renal or hepatic impairment and elderly patients.


### **Q2: What is the mechanism of action of Pentoxifylline?**
**A:**  Pentoxifylline decreases blood viscosity primarily by increasing red blood cell deformability and inhibiting platelet aggregation.  This improves blood flow, particularly in the microcirculation.


### **Q3: What are the most common side effects of Pentoxifylline?**
**A:** The most common side effects include nausea, vomiting, dyspepsia, dizziness, headache, and flushing.


### **Q4: Is Pentoxifylline safe to use during pregnancy?**
**A:** Pentoxifylline is Pregnancy Category C and should generally be avoided during pregnancy unless the benefit clearly outweighs the potential risk to the fetus.


### **Q5:  What are the contraindications for using Pentoxifylline?**
**A:**  Pentoxifylline is contraindicated in patients with hypersensitivity to the drug or other methylxanthines, recent cerebral or retinal hemorrhage, and acute myocardial infarction.


### **Q6:  How should Pentoxifylline be administered?**
**A:**  Pentoxifylline should be administered orally, preferably with meals, to reduce gastrointestinal side effects.  Extended-release formulations should be swallowed whole and not crushed or chewed.


### **Q7: Does Pentoxifylline interact with other medications?**
**A:** Yes, it can interact with antihypertensives, anticoagulants, cimetidine, and theophylline.  It can also interact with drugs metabolized by CYP1A2 and CYP2D6.


### **Q8: How long does it take for Pentoxifylline to work?**
**A:** It may take up to two months to see the full therapeutic effect of Pentoxifylline.


### **Q9: Can Pentoxifylline be used in children?**
**A:** The safety and efficacy of pentoxifylline have not been established in children, and it is generally not recommended for pediatric use.



### **Q10: What monitoring is recommended for patients taking Pentoxifylline?**
**A:** Monitor blood pressure, complete blood count (CBC), and liver function tests regularly, especially in patients with pre-existing conditions.  Monitor for signs of bleeding.
